Arctic Bioscience AS (OSL:ABS) Change In Receivables : kr5.21 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Change In Receivables?

Arctic Bioscience AS's change in receivables for the quarter that ended in Jun. 2024 was kr-1.80 Mil. It means Arctic Bioscience AS's Accounts Receivable increased by kr1.80 Mil from Dec. 2023 to Jun. 2024 .

Arctic Bioscience AS's change in receivables for the fiscal year that ended in Dec. 2023 was kr3.91 Mil. It means Arctic Bioscience AS's Accounts Receivable declined by kr3.91 Mil from Dec. 2022 to Dec. 2023 .

Arctic Bioscience AS's Accounts Receivable for the quarter that ended in Jun. 2024 was kr11.37 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Arctic Bioscience AS's Days Sales Outstanding for the six months ended in Jun. 2024 was 123.94.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Arctic Bioscience AS's liquidation value for the six months ended in Jun. 2024 was kr5.56 Mil.

Arctic Bioscience AS Change In Receivables Historical Data

The historical data trend for Arctic Bioscience AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Change In Receivables Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.70

3.30

-5.77

3.91

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial						-2.83	-2.94	-3.10	7.01	-1.80

Arctic Bioscience AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr5.21 Mil.

Arctic Bioscience AS (OSL:ABS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Arctic Bioscience AS's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	11.373	/	16.746	*	91
=	123.94

2. In Ben Graham's calculation of liquidation value, Arctic Bioscience AS's accounts receivable are only considered to be worth 75% of book value:

Arctic Bioscience AS's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	19.831	-	38.116	+	0.75 * 11.373	+	0.5 * 30.626
=	5.56

Arctic Bioscience AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

9TD:Germany

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines